首页> 外文期刊>Pharmaceutical Biology >Construction of the co-expression plasmids of fostriecin polyketide synthases and heterologous expression in Streptomyces
【24h】

Construction of the co-expression plasmids of fostriecin polyketide synthases and heterologous expression in Streptomyces

机译:曲霉素聚酮化合物合酶共表达质粒的构建及在链霉菌中的异源表达

获取原文
获取外文期刊封面目录资料

摘要

Context: Polyketides are bioactive natural products with diverse bioactivities, and heterologous production of polyketides in easily engineered microbial hosts is preferred for the production of structurally diverse and the therapeutically active polyketides.Objective: In this study, heterologous expression of the biosynthetic genes encoding type I polyketide synthases (PKS) involved in biosynthesis of fostriecin, a unique phosphate monoester polyketide antibiotic, was attempted.Materials and methods: Fostriecin PKS (Fos-PKS) biosynthetic gene cluster in a total of 48.4?kb were cloned downstream of the act I promoter in two compatible Streptomyces vectors using Red/ET recombination. The co-expression plasmids were sequentially transferred into Streptomyces lividans and Streptomyces coelicolor. Active transcription of the polyketide genes was confirmed by reverse transcription PCR (RT-PCR) analysis, and the metabolites were detected using high-performance liquid chromatography (HPLC).Results: The recombinant strains S. lividans TK24/p6-fosAB–p4-fosCDEF and S. coelicolor M512/p6-fosAB–p4-fosCDEF were obtained for heterologous expression in Streptomyces. Pigmentation was observed in the recombinant strains, whereas the control strain with empty vector displayed no change in pigment production. Active transcription of the polyketide genes was confirmed by RT-PCR analysis and subsequent sequencing.Conclusion: The present study is the first attempt to overexpress Fos-PKS biosynthetic gene cluster in Streptomyces. More studies on heterologous expression of the fostriecin biosynthetic gene cluster would be beneficial for further understanding the mechanisms of its structural as well as the potential pharmaceutically effect.
机译:背景:聚酮化合物是具有多种生物活性的生物活性天然产物,并且在易于工程改造的微生物宿主中异源生产聚酮化合物是生产结构多样和具有治疗活性的聚酮化合物的目的。尝试合成参与磷酸酯单酯聚酮化合物氟司汀的生物合成的聚酮化合物合酶(PKS)。材料与方法:在第I启动子的下游克隆了总共48.4kb的聚苯乙烯素PKS(Fos-PKS)生物合成基因簇。使用Red / ET重组在两个兼容的链霉菌载体中克隆将共表达质粒顺序转移至淡链链霉菌和coelicolor链霉菌中。通过逆转录PCR(RT-PCR)分析证实了聚酮化合物基因的主动转录,并使用高效液相色谱(HPLC)检测了代谢产物。结果:重组菌株S. lividans TK24 / p6-fosAB–p4- fosCDEF和链球菌M512 / p6-fosAB–p4-fosCDEF用于链霉菌中的异源表达。在重组菌株中观察到色素沉着,而带有空载体的对照菌株在色素生成上没有显示变化。通过RT-PCR分析和随后的测序证实了聚酮化合物基因的主动转录。结论:本研究是在链霉菌中过表达Fos-PKS生物合成基因簇的首次尝试。关于异戊二烯生物合成基因簇的异源表达的更多研究将有助于进一步了解其结构机理以及潜在的药物作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号